Skip to main content

BIOLIFE SOLUTIONS INC

For the period ended Dec 31, 2024. Filed Mar 3, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 3, 2025

BLFS$38.61+3.5%Stored close · as of Oct 5, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date:March 3, 2025BIOLIFE SOLUTIONS, INC.
/s/ RODERICK DE GREEF
Roderick de Greef
Chief Executive Officer (principal executive officer) and Chairman of the Board of Directors

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Date:March 3, 2025/s/ RODERICK DE GREEF
Roderick De Greef
Chief Executive Officer (principal executive officer) and Chairman of the Board of Directors
Date:March 3, 2025/s/ TROY WICHTERMAN
Troy Wichterman
Chief Financial Officer (principal financial officer and principal accounting officer)
Date:March 3, 2025/s/ AMY DUROSS
Amy DuRoss
Director
Date:March 3, 2025/s/ RACHEL ELLINGSON
Rachel Ellingson
Director
Date:March 3, 2025/s/ JOYDEEP GOSWAMI
Joydeep Goswami
Director
Date:March 3, 2025/s/ TONY HUNT
Tony Hunt
Director
Date:March 3, 2025/s/ TIM MOORE
Tim Moore
Director
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.